ArticleFrontiers in pharmacology2022

Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways.

Chongchong Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.